Compositions and methods for accurately identifying mutations
US-2024409996-A1 · Dec 12, 2024 · US
US9657291B2 · US · B2
| Field | Value |
|---|---|
| Publication number | US-9657291-B2 |
| Application number | US-201514798558-A |
| Country | US |
| Kind code | B2 |
| Filing date | Jul 14, 2015 |
| Priority date | Jan 9, 2008 |
| Publication date | May 23, 2017 |
| Grant date | May 23, 2017 |
A practical reading order for non-experts. Skip the full description unless you need deep technical detail.
What the patent document calls the invention.
A short plain-language summary of the technical disclosure.
Who owns or filed the patent and who is credited as inventor.
Filing, priority, publication, and grant dates set the timeline.
The legal scope of protection — read this for what is actually claimed.
Technology tags used to group this patent with similar filings.
Prior art links and similar publications in this corpus.
Official abstract text for this publication.
The present disclosure relates to methods and compositions for making paired tags and paired tag libraries.
Opening claim text (preview).
What is claimed is: 1. A plurality of circular nucleic acid molecules, the individual circular molecules in the plurality comprising: (a) a first and a second adapter sequence common to the plurality of circular nucleic acid molecules, wherein each of the first and the second adapter sequences are less than 100 bases in length; and (b) a target sequence region that differs between different molecules of the plurality of circular molecules, wherein each target sequence region comprises a fragment of genomic DNA comprising between 200 bp and 15 kb, wherein each of the circular nucleic molecules comprise a first and second nick in the target sequence, one on each strand of the circular nucleic acid molecule, wherein the first and second nick are each located at different positions within the target sequence region. 2. The molecules of claim 1 , wherein the first and the second adapter sequences comprise a double-stranded nucleic acid. 3. The molecules of claim 1 , wherein the first and the second adapter sequences further comprise a binding moiety. 4. The molecules of claim 3 , wherein the binding moiety comprises biotin. 5. The molecules of claim 3 , wherein the binding moiety comprises streptavidin. 6. The molecules of claim 1 , further comprising a nick translating enzyme bound to the nucleic acid molecules. 7. The molecules of claim 6 , wherein the nick translating enzyme comprises DNA polymerase I. 8. A plurality of circular nucleic acid molecules, the individual circular molecules in the plurality comprising: (a) a first and a second adapter sequence common to the plurality of circular nucleic acid molecules, wherein each of the first and the second adapter sequences are less than 100 bases in length; (b) a target sequence region that differs between different molecules of the plurality of circular molecules, wherein each target sequence region comprises a fragment of genomic DNA comprising between 200 bp and 15 kb; and (c) a first and second nick, one on each strand of the circular nucleic acid molecule, located at different positions between an end of the first adapter sequence and an end of the second adapter sequence. 9. The molecules of claim 8 , wherein the first adapter sequence comprises a double-stranded nucleic acid. 10. The molecules of claim 8 , wherein the first adapter sequence further comprises a binding moiety. 11. The molecules of claim 10 , wherein the binding moiety comprises biotin. 12. The molecules of claim 10 wherein the binding moiety comprises streptavidin. 13. The molecules of claim 8 , further comprising a nick translating enzyme bound to the plurality of circular nucleic acid molecules. 14. The molecules of claim 13 , wherein the nick translating enzyme comprises DNA polymerase I. 15. The molecules of claim 1 , wherein target sequence region is derived from the human genome. 16. The molecules of claim 8 , wherein target sequence region is derived from the human genome. 17. The molecules of claim 1 , wherein the target sequence region is derived from random fragments generated from a genomic library. 18. The molecules of claim 8 , wherein the target sequence region is derived from random fragments generated from a genomic library. 19. The molecules of claim 17 , wherein the random fragments are generated from an entire genome. 20. The molecules of claim 18 , wherein the random fragments are generated from an entire genome. 21. The molecules of claim 1 , wherein the first nick is located between 10 and 2000 nucleotides from an end of the first adapter sequence and the second nick is located between 10 and 2000 nucleotides from an end of the second adapter sequence. 22. The molecules of claim 1 , wherein the first nick is located between 10 and 500 nucleotides from an end of the first adapter sequence and the second nick is located between 10 and 500 nucleotides from an end of the second adapter sequence. 23. The molecules of claim 1 , wherein the first nick is located between 10 and 200 nucleotides from an end of the first adapter sequence and the second nick is located between 10 and 200 nucleotides from an end of the second adapter sequence. 24. The molecules of claim 1 , wherein the first nick is located between 10 and 100 nucleotides from an end of the first adapter sequence and the second nick is located between 10 and 100 nucleotides from an end of the second adapter sequence.
involving nucleic acid arrays, e.g. sequencing by hybridisation · CPC title
General methods of preparing gene libraries, not provided for in other subgroups · CPC title
Methods for sequencing · CPC title
Single stranded exonuclease · CPC title
incorporating an adaptor · CPC title
Related publications grouped by family.
Answers are generated from the same data shown on this page.